Integrating genomic, proteomic, and bioinformatic analyses for cancer drug discovery.

被引：0

作者：

Weinstein, JN ^{[1
]}

Reinhold, WC ^{[1
]}

Nishizuka, S ^{[1
]}

Bussey, K ^{[1
]}

Kohn, KW ^{[1
]}

Pommier, Y ^{[1
]}

Zeeberg, B ^{[1
]}

Kim, S ^{[1
]}

Lababidi, S ^{[1
]}

机构：

[1] NCI, Bethesda, MD 20892 USA

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：6124S / 6124S

页数：1

共 50 条

[1] Genomic approaches to drug discovery.
Golub, Todd
CLINICAL CANCER RESEARCH, 2018, 24 (02) : 19 - 19
[2] Discovery informatics: Integrating genomics and proteomics for drug discovery.
Adams, MD
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U470 - U470
[3] Distributing genomic data for cancer discovery.
Rioth, Matthew J.
Staggs, David
Hackett, Lauren
Sberna, Theresa
Lovly, Christine Marie
Levy, Mia Alyce
Warner, Jeremy
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[4] Redox signaling for cancer drug discovery.
Powis, G
CLINICAL CANCER RESEARCH, 1999, 5 : 3879S - 3879S
[5] Integration of genomic, biological, and chemical data in drug discovery.
Laz, T
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U351 - U352
[6] Genetic approaches to cancer drug discovery.
Dunstan, HM
Szankasi, P
Lamb, JL
Simon, JA
Hartwell, LH
Friend, SH
CLINICAL CANCER RESEARCH, 1999, 5 : 3776S - 3776S
[7] The use of NMR in cancer drug discovery.
Fesik, SW
CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3827S - 3827S
[8] Industrialization of drug discovery.
Handen, JS
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U472 - U472
[9] Pharmacophores in drug discovery.
Milne, GWA
Wang, SM
Nicklaus, MC
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 214 : 47 - CINF
[10] Venturing into drug discovery.
Steinmetz M.
Nature Biotechnology, 1998, 16 (Suppl 1) : 17 - 17